Article complete

Bosch Develops Rapid Test To Combat COVID-19

Bosch Develops Rapid Test To Combat COVID-19

Key takeaways

  • Bosch has developed a fully automated rapid test for COVID-19, enabling fast diagnoses in medical facilities.
  • The rapid test can detect a SARS-CoV-2 infection in under two and a half hours from sample collection.
  • Testing can be conducted at the point of care, reducing the need for sample transportation and saving time.
  • The Bosch test can also simultaneously test for nine other respiratory diseases with over 95 percent accuracy.
  • The new test will initially be available in Germany, with plans for rollout in other European markets.

Takeaways drafted with AI from the article text.

Recently, German tech-giant Bosch announced its new, fully automated rapid test for COVID-19, Bosch Vivalytic analyzer, which can help medical facilities such as doctors’ offices, hospitals, laboratories, and health centres make fast diagnoses. Bosch Healthcare Solutions subsidiary collaborated with the Northern Irish medical technology company Randox Laboratories Ltd. to develop Bosch rapid molecular diagnostic test which runs on the Vivalytic analysis device from Bosch Healthcare Solutions. 

Chairman of the board of management of Robert Bosch GmbH, Dr. Volkmar Denner said, “We want the Bosch rapid COVID-19 test to play a part in containing the coronavirus pandemic as quickly as possible. It will speed up the identification and isolation of infected patients.”

According to the blog post, the automate rapid test is developed in just six weeks which has the capability to test and detect a SARS-CoV-2 coronavirus infection in patients in under two and a half hours, measured from the time the sample is taken to the time the result arrives.

Another advantage of the Vivalytic analyser is that it can be performed directly at the point of care, eliminating the need to transport samples, which takes up valuable time. The rapid test allows a single sample to be tested not just for COVID-19 but also for nine other respiratory diseases, including influenza A and B, simultaneously. 

In various laboratory tests with SARS-CoV-2, the Bosch test delivered results with an accuracy of over 95 percent. The newly developed test will be available in Germany starting in April, with other markets in Europe and elsewhere to follow.

CEO of Bosch stated, “Bosch’s rapid COVID-19 test will help contain the spread of the pandemic and break the chain of transmission more quickly.”

Published

Spotted an error? Tell our editors. Read our editorial standards and corrections.

More in this story

bosch · 5 stories
  1. Bosch To Invest ₹17 Billion In India, Will Focus On Expanding Bengaluru Smart Campus
  2. No Digital Ecosystem Is Self-Sufficient; Collaboration Is The Key, Says Dattatri Salagame Of Bosch
  3. You are here: Bosch Develops Rapid Test To Combat COVID-19
  4. Interview: How Bosch Uses AI To Transform Its Manufacturing Processes
  5. OpenAI is Nothing Like Tata Trusts’ Board Structure
About the author

Contributor

A Technical Journalist who loves writing about Machine Learning and Artificial Intelligence. A lover of music, writing and learning something out of the box.

All stories
Belamy · Daily

The day’s AI news, before your first meeting.